Clinical trial
Tissue Regeneration and Function Recovery in Patients With Parkinson's Disease Using Allogenic Pluripotent Stem Cells Isolated From Adipose Tissue (PASCs): A Randomized Phase I/IIa Clinical Trial (REPOSE)
NCT06141317 is registered in ClinicalTrials.gov with ClusterXStem-Costa Rica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tissue Regeneration and Function Recovery in Patients With Parkinson's Disease Using Allogenic Pluripotent Stem Cells Isolated From Adipose Tissue (PASCs): A Randomized Phase I/IIa Clinical Trial (REPOSE)
- Lead sponsor
- ClusterXStem-Costa Rica
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- June 23, 2023
- Completion date
- November 1, 2024
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.